Drug Use Disorder Treatment
Drug Use Disorder is the umbrella term for compulsive use of illicit or non-prescribed substances. Effective treatment combines medical care, behavioral therapy, and ongoing recovery support — and is covered by most insurance plans under federal parity law.
About Drug Use Disorder
The DSM-5 organizes drug use disorders by substance class: stimulants (cocaine, methamphetamine, prescription stimulants), sedatives (benzodiazepines, sleep medications), cannabis, hallucinogens, inhalants, and others. Opioid Use Disorder is treated separately on our dedicated opioid pages. Each substance class has distinct medical, behavioral, and withdrawal considerations — but all share the same DSM-5 criteria structure (mild, moderate, severe based on 11 criteria) and respond to similar evidence-based treatment approaches.
Withdrawal & Medical Considerations
Withdrawal varies significantly by substance. Stimulant withdrawal (cocaine, meth) is psychologically intense — fatigue, depression, intense cravings — but not typically medically dangerous. Sedative/benzodiazepine withdrawal CAN be life-threatening and requires medical supervision and a slow taper. Cannabis withdrawal is real but mild for most users (irritability, sleep disturbance, decreased appetite for 1-2 weeks). Hallucinogen and inhalant withdrawal patterns differ. A clinical assessment is the first step.
Medications & Treatment
Medication-assisted treatment varies by substance. There are no FDA-approved medications for stimulant or cannabis use disorders — treatment relies on behavioral therapies (Contingency Management has the strongest evidence for stimulants). For sedative use disorder, the protocol is a slow taper using long-acting agents like diazepam or clonazepam. For polysubstance use involving opioids, MAT options (buprenorphine, methadone, naltrexone) apply.
Frequently Asked Questions
What drugs does the DSM-5 cover?
Stimulants (cocaine, methamphetamine, ADHD medications), sedatives and hypnotics (benzodiazepines, sleep medications), cannabis, hallucinogens (LSD, psilocybin, PCP, ecstasy), and inhalants. Opioids and alcohol are tracked separately.
Is cocaine or meth withdrawal dangerous?
Stimulant withdrawal is generally not medically dangerous but is psychologically severe — intense fatigue, depressed mood, sleep problems, vivid cravings. The bigger medical concerns are cardiovascular damage from active use, depression-related suicide risk in withdrawal, and the high relapse risk early in recovery.
Why is benzodiazepine withdrawal so risky?
Like alcohol, benzodiazepines affect GABA neurotransmission. Stopping abruptly after sustained use can cause seizures, severe autonomic instability, and protracted withdrawal that can take months to fully resolve. Always taper under medical supervision.
What is the best treatment for stimulant use disorder?
Contingency Management — providing tangible rewards for negative drug tests — has the strongest evidence base. Cognitive-behavioral therapy, motivational interviewing, and the Matrix Model are also widely used. There are no FDA-approved medications, though some studies suggest off-label options.
How long is drug rehab?
Length of stay depends on substance, severity, co-occurring conditions, and treatment goals. Typical residential treatment is 30-90 days. Step-down to PHP or IOP often runs 4-12 weeks. Outpatient and recovery support usually continue for 12+ months. Longer engagement is consistently associated with better outcomes.
Find the Right Treatment for Drug Use Disorder
Free, confidential phone assessment — same day.866-644-7911Verify Online